P30
Prostate cancer is presented as the most commonly diagnosed cancer in men. According to statistical reports, every 6th man have the prostate cancer and out of them every 34th man will have the castrate-resistant form of disease. The existing clinical and prognostic factors can explain cancer outcome...
Main Authors: | N. Tarasenko, L. Spirina, E. Usynin, A. Gorbunov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-11-01
|
Series: | EJC Supplements |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1359634915001093 |
Similar Items
-
TRIM16 transcription factor in prostate cancer
by: L. V. Spirina, et al.
Published: (2018-09-01) -
Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01) -
TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION
by: L. V. Spirina, et al.
Published: (2018-03-01) -
ROLE OF NEUREGULINS AND HEPATOCYTE GROWTH FACTOR IN THE DEVELOPMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: L. V. Spirina, et al.
Published: (2016-02-01) -
THE ACTIVITY OF PROTEASOMES AND THEIR SUBUNIT COMPOSITION IN CANCER OF THE KIDNEY AND URINARY BLADDER
by: L. V. Spirina, et al.
Published: (2014-07-01)